GlobeNews Wire

IP Strategy Issues Statement on Arias Frontline K-Pop Release with RESCENE, Highlighting AI-Native Music Ownership on Story

GIG HARBOR, Wash., Feb. 17, 2026 (GLOBE NEWSWIRE) -- IP Strategy (Nasdaq: IPST) (the “Company”) today issued a statement recognizing…

3 weeks ago

NSA Labs Helps Leading Biopharmaceutical Companies Get Study Results Faster on Proscias Platform

Specialized CRO has delivered 750 neuroscience studies advancing drug R&D with digital pathology February 17, 2026 08:00 ET  | Source:…

3 weeks ago

Oculis Appoints Katie Kazem as Chief Legal Officer

Ms. Kazem brings extensive and global expertise in corporate governance and securities law, drawing on a distinguished track record as…

3 weeks ago

FundaMental Pharma to showcase groundbreaking approach to treatment-resistant depression at Bio-Neuroscience Conference

Presentation will highlight lead clinical candidate FMP374, a novel dual-acting NMDAR modulator advancing toward IND-enabling studies for TRD HEIDELBERG, Germany,…

3 weeks ago

Inventiva reports preliminary 2025 fiscal year financial results

Cash and cash equivalents at €99.3 million, and €131.6 million in short-term deposits2 as of December 31, 2025Revenues of €4.5…

3 weeks ago

TTEC Sets New Standard for AI-Driven Frontline Performance with TTEC Perform and TTEC RealSkill

AUSTIN, Texas, Feb. 16, 2026 (GLOBE NEWSWIRE) -- TTEC Holdings, Inc. (NASDAQ: TTEC), a leading global CX (customer experience) technology…

3 weeks ago

UTI GROUP : Nominations et acquisition du groupe MALTEM par ROBINSON TECHNOLOGIES

A la suite de l’Assemblée Générale Extraordinaire qui s’est tenue le lundi 16 février 2026, Monsieur Romain Aumard et Monsieur…

3 weeks ago

Transactions in connection with share buyback programme

Company announcement No. 13/2026                                                  16 February 2026 Transactions in connection with share buyback programmeOn 3 February 2026, Netcompany Group…

3 weeks ago

Harness Therapeutics Nominates HRN001, a First-in-Class Drug Candidate for Huntingtons Disease and Establishes Clinical Advisory Board

HRN001 is a potent and specific antisense oligonucleotide designed to drive controlled upregulation of FAN1, a genetically validated target in…

3 weeks ago

Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470

Press Release Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470U.S. NDA submission on track for…

3 weeks ago